Join PharmaDispatch
Subscribe
Login
Explore the Site
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BioPharmaDispatch
Menu
October 08, 2025
Subscribe
Login
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Latest Video
Most Read
AusBiotech’s annual report highlights a defining year for Australia’s life sciences sector
October 7, 2025 - Australian Biotech
AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime
October 7, 2025 - Latest News
New report highlights widening gap in access to modern medicines between Australia and NZ
October 8, 2025 - Latest News
Patients, policy and productivity - a call for faster access to innovation
October 7, 2025 - Latest News
The theology of syntax and how HTA exercises power through language
October 6, 2025 - Latest News
Follow Us
LinkedIn
Twitter
Instagram
New Stories
New report highlights widening gap in access to modern medicines between Australia and NZ
October 8, 2025 - - Latest News
RACGP warns of mounting pressure on GPs as costs and complexity rise
October 7, 2025 - - Other Health
AusBiotech’s annual report highlights a defining year for Australia’s life sciences sector
October 7, 2025 - - Australian Biotech
AstraZeneca becomes the latest to say it could halt UK investment over 'appalling' pricing regime
October 7, 2025 - - Latest News
MTPConnect and Wholesale Investor unite to accelerate investment in life sciences sector
October 7, 2025 - - Australian Biotech
Percheron Therapeutics reports positive final data from early-phase trial of HMBD-002
October 7, 2025 - - Australian Biotech
FDA clears clinical hold on Neurizon's NUZ-001, paving way for HEALEY ALS trial
October 7, 2025 - - Australian Biotech